Skip to main
RVTY

Revvity Inc (RVTY) Stock Forecast & Price Target

Revvity Inc (RVTY) Analyst Ratings

Based on 14 analyst ratings
Hold
Strong Buy 14%
Buy 21%
Hold 64%
Sell 0%
Strong Sell 0%

Bulls say

Revvity is a leading life sciences and diagnostics company with a strong focus on pre-clinical work and potential for long-term growth in AI-enabled drug discovery. While the divestiture in 2023 is expected to improve profitability and organic growth, challenges in the industry may impact these goals. The acquisition of EUROIMMUN has strengthened Revvity's presence in the US and the company's performance in the Reproductive Health segment is strong. However, competition and doubts about the sustainability of growth in Immunodiagnostics may pose potential risks for the company's future.

Bears say

Revvity is facing several challenges that contribute to a negative outlook on its stock. The company's immunodiagnostics and reproductive health business, which has been a major growth driver, is facing headwinds due to divestment of its China exposure and low growth in the UK. Additionally, the company's recent acquisitions of Euroimmun and BioLegend have not lived up to expectations, and there are concerns about the sustainability of the company's long-term growth projections as it faces competition and challenges in its key markets. Furthermore, Revvity's focus on signals software may not be enough to offset the challenges in its life sciences business, and downside risks such as macroeconomic conditions and M&A integration could further negatively impact the company's performance.

Revvity Inc (RVTY) has been analyzed by 14 analysts, with a consensus rating of Hold. 14% of analysts recommend a Strong Buy, 21% recommend Buy, 64% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Revvity Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Revvity Inc (RVTY) Forecast

Analysts have given Revvity Inc (RVTY) a Hold based on their latest research and market trends.

According to 14 analysts, Revvity Inc (RVTY) has a Hold consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $116.43, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $116.43, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Revvity Inc (RVTY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.